British health officials on Wednesday warned that non-urgent hospital operations could be cancelled due to a shortage in blood stocks, calling for more supplies.
Oct 12, 2022
0
2
American drugmaker Pfizer is close to a deal to purchase Global Blood Therapeutics, which manufactures a recently approved drug against sickle-cell anemia, for $5 billion, the Wall Street Journal has reported.
Aug 7, 2022
0
4
China began its most extensive coronavirus lockdown in two years Monday to conduct mass testing and control a growing outbreak in Shanghai as questions are raised about the economic toll of the nation's "zero-COVID" strategy.
Mar 28, 2022
0
10
British drugs giant GlaxoSmithKline said Tuesday that its consumer healthcare division will be spun off later this year under the name Haleon.
Feb 22, 2022
0
10
Dutch electronics giant Philips said Wednesday it has set aside a further 225 million euros for a recall of faulty respiratory equipment that puts users at risk of inhaling toxic foam.
Jan 12, 2022
0
2
Swiss pharmaceutical giant Novartis said Tuesday it is reviewing the future of its generic medicine division Sandoz, with all options on the table—including spinning it off.
Oct 26, 2021
0
23
Hong Kong suspended use of the Pfizer vaccine Wednesday after its Chinese distributor informed the city that one batch had defective bottle lids.
Mar 24, 2021
0
2
China's drug authority has approved for clinical trials an inhaled COVID-19 vaccine co-developed by domestic firm CanSino Biologics, the company said in a filing on Tuesday.
Mar 23, 2021
0
4
Pascal Soriot has led the charge to make AstraZeneca one of the first pharmaceutical companies in the world to produce a vaccine against COVID-19.
Mar 18, 2021
0
2
One of the teams racing to develop a coronavirus vaccine announced Monday its drug had shown 90 percent effectiveness, sending markets soaring and raising hopes of an end to the worst pandemic in a century.
Nov 9, 2020
0
1
